Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer
Clinical trial NCT03262545 · UNKNOWN
Trial details
- NCT number
- NCT03262545
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-27
- Primary completion
- 2020-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.